Mrs Summer Dawn Feaster, LICSW | |
9040 Reid Street, Attn: Mchj-clq-q, Tacoma, AA 98431-1100 | |
(253) 968-2252 | |
(253) 968-3278 |
Full Name | Mrs Summer Dawn Feaster |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 9040 Reid Street, Tacoma, Armed Forces Americas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467939959 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | LW60807313 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Summer Dawn Feaster, LICSW 20021 96th Avenue Ct E, Graham, WA 98338-8281 Ph: (206) 550-4860 | Mrs Summer Dawn Feaster, LICSW 9040 Reid Street, Attn: Mchj-clq-q, Tacoma, AA 98431-1100 Ph: (253) 968-2252 |
News Archive
Most adolescent survivors of childhood cancer have no reported psychological symptoms, but an analysis led by St. Jude Children's Research Hospital found that those who do often have multiple symptoms and distinct symptom profiles.
Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances.
Three separate studies announced today at the American Society of Hypertension Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010) examined the cardiovascular consequences of relatively healthy patients - those who were asymptomatic and not classified as hypertensive or diabetic - and found that many patients who appear healthy may still be at risk for cardiovascular disease.
HRSA has awarded $1.6 million to support the Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The program is designed to establish practice models for the prevention and treatment of sickle cell disease through the coordinated efforts of providers, key stake holders, affected individuals and their families.
Noveko International Inc. ("the Company") is pleased to announce that further to its request, the Food and Drugs Administration (the "FDA") accepted to meet with the Company, to consider an additional labelling claim for its Noveko(TM) masks and respirators.
› Verified 6 days ago